Skip to main content

Advertisement

SpringerLink
Log in

Predictors for Early Recurrence After Hepatectomy for Initially Unresectable Colorectal Liver Metastasis

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

Early recurrence correlates with poor survival following various cancer surgeries and puts considerable stress on patients both physically and mentally. This retrospective study investigated the predictive factors for early recurrence after surgical resection for initially unresectable colorectal liver metastasis to elucidate indications for conversion strategies.

Methods

We retrospectively studied 46 patients who underwent hepatectomy after chemotherapy for initially unresectable colorectal liver metastasis from 1997 to 2010.

Results

Recurrences occurred within 6 months after hepatectomy in 13 patients (37 %). The median survival time of 21.2 months and the 5-year survival rate of 0 % after hepatectomy in patients with recurrence within 6 months were significantly worse than those in patients with recurrence more than 6 months after hepatectomy. Recurrence in less than 6 months was significantly correlated with impossibility of anticancer therapy for recurrence after hepatectomy (p = 0.01). Eight or more hepatic tumors after chemotherapy were the only predictor of recurrence within 6 months (p = 0.01; odds ratio 9.6; 95 % confidence interval 1.5–60.6).

Conclusion

Recurrence within 6 months was significantly correlated with a poorer outcome following surgery for initially unresectable colorectal liver metastasis. Surgical indication for initially unresectable colorectal liver metastasis with eight or more hepatic tumors after chemotherapy should be considered carefully in the light of mental and physical status, co-morbidity, and alternative treatment plans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Annals of Surgery 2004;239:818–25; discussion 25–7.

    Article  PubMed  Google Scholar 

  2. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Annals of Surgery 2002;235:759–66.

    Article  PubMed  Google Scholar 

  3. Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P, et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. The British Journal of Surgery 1997;84:977–80.

    Article  PubMed  CAS  Google Scholar 

  4. Adson MA. Resection of liver metastases—when is it worthwhile? World J Surg 1987;11:511–20.

    Article  PubMed  CAS  Google Scholar 

  5. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59–71.

    Article  PubMed  CAS  Google Scholar 

  6. Delaunoit T, Alberts SR, Sargent DJ, Green E, Goldberg RM, Krook J, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol 2005;16:425–9.

    Article  PubMed  CAS  Google Scholar 

  7. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009;27:3677–83.

    Article  PubMed  Google Scholar 

  8. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663–9.

    Article  PubMed  CAS  Google Scholar 

  9. Adam R, Wicherts DA, de Haas RJ, Ciacio O, Levi F, Paule B, et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 2009;27:1829–35.

    Article  PubMed  Google Scholar 

  10. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 2011;29:1083–90.

    Article  PubMed  Google Scholar 

  11. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509–20; discussion 20–2.

    Article  PubMed  CAS  Google Scholar 

  12. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644–57; discussion 57–8.

    Google Scholar 

  13. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052–61; discussion 61–4.

    Article  PubMed  Google Scholar 

  14. Blazer DG, 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 2008;26:5344–51.

    Article  PubMed  Google Scholar 

  15. Schrodter S, Hakenberg OW, Manseck A, Leike S, Wirth MP. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma. The Journal of Urology 2002;167:1630–3.

    Article  PubMed  Google Scholar 

  16. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Annals of Surgery 2003;238:703–10.

    Article  PubMed  Google Scholar 

  17. Kurtz JM, Amalric R, Brandone H, Ayme Y, Jacquemier J, Pietra JC, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer 1989;63:1912–7.

    Article  PubMed  CAS  Google Scholar 

  18. Takahashi S, Konishi M, Nakagohri T, Gotohda N, Saito N, Kinoshita T. Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. Jpn J Clin Oncol 2006;36:368–75.

    Article  PubMed  Google Scholar 

  19. Malik HZ, Gomez D, Wong V, Al-Mukthar A, Toogood GJ, Lodge JPA, et al. Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Ejso 2007;33:1003–9.

    Article  PubMed  CAS  Google Scholar 

  20. Chijiiwa K, Watanabe M, Nakano K, Noshiro H, Tanaka M. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice. Am J Surg 2000;179:161–6.

    Article  PubMed  CAS  Google Scholar 

  21. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997;26:1176–81.

    PubMed  CAS  Google Scholar 

  22. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984;95:586–92.

    PubMed  CAS  Google Scholar 

  23. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute 2000;92:205–16.

    Article  PubMed  CAS  Google Scholar 

  24. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery 2004;240:205–13.

    Article  PubMed  Google Scholar 

  25. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004;240:1037–49; discussion 49–51.

    Article  PubMed  Google Scholar 

  26. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1–7.

    Article  PubMed  Google Scholar 

  27. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology 2006;24:2065–72.

    Article  CAS  Google Scholar 

  28. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008;247:118–24.

    Article  PubMed  Google Scholar 

  29. Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 2012;255:237–47.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Hepato-biliary Pancreatic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, 277-8577, Chiba, Japan

    Shinichiro Takahashi, Masaru Konishi, Takahiro Kinoshita, Naoto Gotohda & Yuichiro Kato

  2. Department of Colorectal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan

    Norio Saito & Masanori Sugito

  3. Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan

    Takayuki Yoshino

Authors
  1. Shinichiro Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaru Konishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takahiro Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naoto Gotohda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuichiro Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Norio Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masanori Sugito
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takayuki Yoshino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shinichiro Takahashi.

Additional information

This paper is not based on a previous communication to a society or meeting.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takahashi, S., Konishi, M., Kinoshita, T. et al. Predictors for Early Recurrence After Hepatectomy for Initially Unresectable Colorectal Liver Metastasis. J Gastrointest Surg 17, 939–948 (2013). https://doi.org/10.1007/s11605-013-2162-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-013-2162-0

Keywords

Search

Navigation